Plain-English translation of NCT07600008 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Czechia
Sponsor
University Hospital Olomouc
Collaborators
Masaryk University
Enrollment target
~50 participants
Started
January 2026
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 55 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Vít Navrátil, MUDr, Ph.D.
University Hospital Olomouc
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.